JPX · 7733.T
Olympus Corporation
¥1,742-¥27 (-1.53%)
Olympus Corporation’s quoted price sits in the lower half of its reported 52-week range, 21.19% below the high.
Loading market information…
JPX · 6523.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
PHC Holdings Corporation’s quoted price sits in the upper half of its reported 52-week range, 16.47% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
PHC Holdings Corporation’s forward annual dividend is ¥42 per share, paid semi-annual. The forward yield is 2.97% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
PHC Holdings Corporation’s next earnings report is currently expected on Nov 11, 2026, with estimated earnings per share of ¥45. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow PHC Holdings Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
PHC Holdings Corporation, through its network of subsidiaries, specializes in the innovation, production, and sale of medical instruments, advanced healthcare technology solutions, and life science merchandise. The company's product line includes blood glucose monitoring systems and a variety of other diagnostic and analytical tools, alongside sophisticated data integration platforms. It also delivers end-to-end anatomical pathology solutions, featuring specialized equipment, microscope slides, and diverse staining reagents. In the life sciences sector, PHC provides essential equipment and support services for sample preservation and cell culture. Furthermore, the company develops and deploys healthcare IT products, focusing on medical information systems designed for clinics and pharmacies dealing with health insurance. Its operations also extend to clinical testing, the manufacturing of diagnostic reagents, and providing support for pharmaceutical development. Established in 2014 and based in Tokyo, Japan, the company was formerly recognized as Panasonic Healthcare Holdings Co., Ltd. before officially changing its name to PHC Holdings Corporation in April 2018.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:37 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q4 2024 | May 13, 2025 | ¥23-37.12% vs estimate | ¥94.68B-0.98% vs estimate |
|---|
| Q3 2024 | Feb 12, 2025 | ¥28-5.11% vs estimate | ¥93.05B+2.72% vs estimate |
|---|
| Q2 2024 | Nov 13, 2024 | ¥58+246.16% vs estimate | ¥88.68B-0.48% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥1,742-¥27 (-1.53%)
Olympus Corporation’s quoted price sits in the lower half of its reported 52-week range, 21.19% below the high.
¥1,942+¥13 (+0.65%)
Sysmex Corporation’s quoted price sits in the upper half of its reported 52-week range, 4.12% below the high.
¥11,410+¥390 (+3.54%)
Fukuda Denshi Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 8.65% below the high.
¥1,617+¥32 (+1.99%)
Nihon Kohden Corporation’s quoted price sits in the upper half of its reported 52-week range, 14.27% below the high.
¥1,421+¥9 (+0.64%)
Nakanishi Inc.’s quoted price sits in the upper half of its reported 52-week range, 16.04% below the high.
¥2,532+¥15 (+0.58%)
Ship Healthcare Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 10.83% below the high.
¥1,513+¥17 (+1.14%)
Mani, Inc.’s quoted price sits in the lower half of its reported 52-week range, 22.61% below the high.
¥2,307+¥6 (+0.26%)
Eiken Chemical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 34.09% below the high.
